Why This Matters More Than Trial DXA Data The SURMOUNT and STEP DXA substudies that established the "25-30% of weight loss is lean mass" baseline were done in trial populations: motivated patients, structured visits, baseline DXA, often dietitian contact
Updated result (January 26, 2026): Roche announced full 48-week Phase II results from the CT388-103 trial (NCT06525935, n=469)
Whether you're considering a semaglutide prescription for the first time or switching from a compounded product to a branded, FDA-approved medication, Klinic can help
Signature confirmation and delivery instructions can help prevent many common delivery problems
Coverage to treat obesity will end Jan
GLP-1 Medications: An Overview Types of GLP-1 Medications Several GLP-1 receptor agonists are currently approved for weight loss and diabetes management